BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23864685)

  • 21. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
    Chambers NE; Coyle M; Sergio J; Lanza K; Saito C; Topping B; Clark SD; Bishop C
    Eur J Neurosci; 2021 Apr; 53(8):2835-2847. PubMed ID: 33426708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment.
    Quik M; Police S; He L; Di Monte DA; Langston JW
    Neuroscience; 2000; 98(2):263-73. PubMed ID: 10854757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spike discharge characteristic of the caudal mesencephalic reticular formation and pedunculopontine nucleus in MPTP-induced primate model of Parkinson disease.
    Goetz L; Piallat B; Bhattacharjee M; Mathieu H; David O; Chabardès S
    Neurobiol Dis; 2019 Aug; 128():40-48. PubMed ID: 30086388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
    Elson JL; Kochaj R; Reynolds R; Pienaar IS
    Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
    Jin X; Schwabe K; Krauss JK; Alam M
    Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.
    Zhao TT; Kim KS; Shin KS; Park HJ; Kim HJ; Lee KE; Lee MK
    BMC Complement Altern Med; 2017 Sep; 17(1):449. PubMed ID: 28877690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease.
    Karachi C; Grabli D; Bernard FA; Tandé D; Wattiez N; Belaid H; Bardinet E; Prigent A; Nothacker HP; Hunot S; Hartmann A; Lehéricy S; Hirsch EC; François C
    J Clin Invest; 2010 Aug; 120(8):2745-54. PubMed ID: 20628197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation.
    Takada M; Matsumura M; Kojima J; Yamaji Y; Inase M; Tokuno H; Nambu A; Imai H
    Eur J Neurosci; 2000 May; 12(5):1771-80. PubMed ID: 10792454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic levodopa administration followed by a washout period increased number and induced phenotypic changes in striatal dopaminergic cells in MPTP-monkeys.
    DiCaudo C; Riverol M; Mundiñano IC; Ordoñez C; Hernández M; Marcilla I; Luquin MR
    PLoS One; 2012; 7(11):e50842. PubMed ID: 23226401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning.
    Goldberg NR; Hampton T; McCue S; Kale A; Meshul CK
    J Neurosci Res; 2011 Oct; 89(10):1698-706. PubMed ID: 21748776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baicalein enhances the effect of low dose Levodopa on the gait deficits and protects dopaminergic neurons in experimental Parkinsonism.
    Zheng ZV; Cheung CY; Lyu H; Chan HY; Li Y; Bian ZX; Wang KKW; Poon WS
    J Clin Neurosci; 2019 Jun; 64():242-251. PubMed ID: 30905662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Masilamoni GJ; Groover O; Smith Y
    Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys.
    Ghorayeb I; Fernagut PO; Stefanova N; Wenning GK; Bioulac B; Tison F
    Neurosci Lett; 2002 Dec; 335(1):34-8. PubMed ID: 12457736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of globus pallidus internus stimulation on neuronal activity in the pedunculopontine tegmental nucleus in the primate model of Parkinson's disease.
    Zhang J; Wang ZI; Baker KB; Vitek JL
    Exp Neurol; 2012 Jan; 233(1):575-80. PubMed ID: 21821025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of low frequency stimulation of the pedunculopontine tegmental nucleus on basal ganglia in a rat model of Parkinson's disease.
    Park E; Song I; Jang DP; Kim IY
    Neurosci Lett; 2014 Aug; 577():16-21. PubMed ID: 24928224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism.
    Park G; Park YJ; Yang HO; Oh MS
    Pharmacol Biochem Behav; 2013 Mar; 104():163-8. PubMed ID: 23369986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons.
    Gouty S; Brown JM; Rosenberger J; Cox BM
    Neuroscience; 2010 Aug; 169(1):269-78. PubMed ID: 20417255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.